Citurgia Biochemicals (BSE 506373)₹102.45−0.97%Commodity Chemicals
In the Mar 2026 quarter (standalone), Citurgia Biochemicals reported sales of ₹0 Cr and net profit of −₹0.25 Cr. For the year to Mar 2026, sales were ₹0 Cr and net profit −₹0.73 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.08 | 0.04 | 0.06 | 0.03 | 0.07 | 0.04 | 0.05 | 0.02 | 0.04 | 0.22 | 0.19 |
| Operating Profit | −0.05 | −0.10 | −0.06 | −0.08 | −0.05 | −0.09 | −0.06 | −0.07 | −0.04 | −0.06 | −0.24 | −0.21 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 |
| Profit before tax | −0.10 | −0.16 | −0.12 | −0.14 | −0.10 | −0.15 | −0.12 | −0.13 | −0.09 | −0.12 | −0.30 | −0.27 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.08 | −0.14 | −0.10 | −0.12 | −0.08 | −0.13 | −0.09 | −0.11 | −0.07 | −0.10 | −0.28 | −0.25 |
| EPS (Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.01 | −0.01 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.15 | 0.09 | 0.17 | 0.23 | 0.11 | 0.36 | 0.17 | 0.20 | 0.24 | 0.19 | 0.51 | 0.47 |
| Operating Profit | −0.17 | −0.11 | −0.19 | −0.25 | −0.13 | −0.38 | −0.19 | −0.22 | −0.26 | −0.21 | −0.53 | −0.55 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.51 | 0.44 | 0.38 | 0.33 | 0.29 | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.27 |
| Profit before tax | −0.67 | −0.54 | −0.56 | −0.57 | −0.41 | −0.62 | −0.42 | −0.45 | −0.49 | −0.44 | −0.76 | −0.78 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Net Profit | −0.65 | −0.53 | −0.54 | −0.55 | −0.39 | −0.60 | −0.39 | −0.43 | −0.47 | −0.41 | −0.73 | −0.70 |
| EPS (Rs) | −0.04 | −0.03 | −0.03 | −0.03 | −0.02 | −0.04 | −0.02 | −0.02 | −0.03 | −0.02 | −0.05 | −0.02 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 26.40 | 26.40 | 26.44 | 26.42 | 26.42 | 26.42 | 26.42 | 26.41 | 26.41 | 26.43 | 26.41 | 26.41 |
| Reserves | −28.26 | −28.91 | −29.48 | −30.03 | −30.56 | −30.97 | −31.59 | −31.97 | −32.42 | −32.90 | −33.31 | −34.05 |
| Borrowings | 4.48 | 4.49 | 5.14 | 6.46 | 6.47 | 6.47 | 6.48 | 6.48 | 6.54 | 6.76 | 6.82 | 6.88 |
| Other Liabilities | 8.55 | 9.63 | 9.88 | 10.00 | 10.08 | 10.08 | 10.31 | 10.55 | 10.68 | 10.79 | 10.87 | 11.25 |
| Total Liabilities | 11.17 | 11.61 | 11.98 | 12.85 | 12.41 | 12.00 | 11.62 | 11.47 | 11.21 | 11.08 | 10.79 | 10.49 |
| Fixed Assets | 3.67 | 3.17 | 2.74 | 2.37 | 2.05 | 1.77 | 1.53 | 1.31 | 1.08 | 0.86 | 0.63 | 0.41 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 7.50 | 8.44 | 9.24 | 10.48 | 10.36 | 10.23 | 10.09 | 10.16 | 10.13 | 10.22 | 10.16 | 10.08 |
| Inventories | 5.18 | 6.14 | 6.80 | 8.06 | 8.09 | 8.08 | 8.09 | 8.09 | 8.09 | 8.08 | 8.09 | 8.09 |
| Cash & equivalents | 0.16 | 0.09 | 0.36 | 0.27 | 0.12 | 0.07 | 0.08 | 0.06 | 0.09 | 0.11 | 0.13 | 0.14 |
| Total Assets | 11.17 | 11.61 | 11.98 | 12.85 | 12.41 | 12.00 | 11.62 | 11.47 | 11.21 | 11.08 | 10.79 | 10.49 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.02 | −0.09 | −0.50 | −1.33 | −0.20 | −0.10 | −0.16 | −0.02 | −0.06 | −0.15 | −0.11 | −0.14 |
| Cash from investing activity | 0.00 | 0.00 | 0.14 | −0.08 | 0.01 | 0.05 | 0.16 | 0.00 | 0.05 | −0.06 | 0.08 | 0.09 |
| Cash from financing activity | 0.00 | 0.00 | 0.66 | 1.31 | 0.04 | 0.00 | 0.02 | 0.00 | 0.07 | 0.23 | 0.07 | 0.07 |
| Net cash flow | −0.04 | −0.09 | 0.28 | −0.10 | −0.16 | −0.07 | 0.02 | −0.02 | 0.03 | 0.04 | 0.02 | 0.02 |
| Free cash flow | −0.02 | −0.07 | −0.50 | −1.31 | −0.18 | −0.10 | −0.14 | −0.02 | −0.06 | −0.13 | −0.11 | −0.12 |
| CFO / OP % | 17.0% | 50.0% | 510.0% | 733.0% | 79.0% | 92.0% | 41.0% | 17.0% | 32.9% | 55.9% | 60.0% | 25.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | −25.9% | −29.5% | −26.9% | −22.9% | −22.3% | −19.6% | −39.6% | −39.6% | −68.2% | −145.4% | −2,149.9% |
For the Mar 2026 quarter, Citurgia Biochemicals reported sales of ₹0 Cr and net profit of −₹0.25 Cr.
Citurgia Biochemicals' sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0 Cr.
Net profit for the year to Mar 2026 was −₹0.73 Cr, and −₹0.70 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.02.
Citurgia Biochemicals reported borrowings of ₹6.88 Cr at Mar 2026, against cash and equivalents of ₹0.14 Cr.
Cash from operations was −₹0.14 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.12 Cr.